BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 16095708)

  • 1. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
    Kivelä T; Puusaari I; Damato B
    Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
    Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
    JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
    Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT; Chin KJ; Tena LB
    Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 125I plaque brachytherapy for anterior uveal melanomas.
    Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
    Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
    Wilson MW; Hungerford JL
    Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
    Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
    Kreissig I; Rose D; Simader E
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
    Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
    Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.